DE60333820D1 - Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumoren - Google Patents
Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumorenInfo
- Publication number
- DE60333820D1 DE60333820D1 DE60333820T DE60333820T DE60333820D1 DE 60333820 D1 DE60333820 D1 DE 60333820D1 DE 60333820 T DE60333820 T DE 60333820T DE 60333820 T DE60333820 T DE 60333820T DE 60333820 D1 DE60333820 D1 DE 60333820D1
- Authority
- DE
- Germany
- Prior art keywords
- fibronectin
- treatment
- domain
- conjugates
- tumors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000016359 Fibronectins Human genes 0.000 title abstract 2
- 108010067306 Fibronectins Proteins 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02000315 | 2002-01-03 | ||
| US35870202P | 2002-02-25 | 2002-02-25 | |
| PCT/EP2003/000009 WO2003055917A2 (en) | 2002-01-03 | 2003-01-02 | Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60333820D1 true DE60333820D1 (de) | 2010-09-30 |
Family
ID=35976951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60333820T Expired - Lifetime DE60333820D1 (de) | 2002-01-03 | 2003-01-02 | Konjugate mit einem für die ed-b-domäne von fibronectin spezifischen antikörper, und deren verwendung zum nachweis und zur behandlung von tumoren |
Country Status (8)
| Country | Link |
|---|---|
| KR (2) | KR100998803B1 (de) |
| AT (1) | ATE478095T1 (de) |
| DE (1) | DE60333820D1 (de) |
| DK (1) | DK1461360T3 (de) |
| ES (1) | ES2346750T3 (de) |
| PT (1) | PT1461360E (de) |
| SI (1) | SI1461360T1 (de) |
| ZA (1) | ZA200406162B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3691771B1 (de) | 2017-10-02 | 2023-08-16 | Battelle Energy Alliance, LLC | Verfahren und systeme zur elektrochemischen reduktion von kohlendioxid unter verwendung von umschaltbaren polaritätsmaterialien |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI259837B (en) * | 1998-05-11 | 2006-08-11 | Eidgenossische Tech Hochscule | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
-
2003
- 2003-01-02 AT AT03726977T patent/ATE478095T1/de not_active IP Right Cessation
- 2003-01-02 SI SI200331895T patent/SI1461360T1/sl unknown
- 2003-01-02 PT PT03726977T patent/PT1461360E/pt unknown
- 2003-01-02 DE DE60333820T patent/DE60333820D1/de not_active Expired - Lifetime
- 2003-01-02 ES ES03726977T patent/ES2346750T3/es not_active Expired - Lifetime
- 2003-01-02 KR KR1020047010498A patent/KR100998803B1/ko not_active IP Right Cessation
- 2003-01-02 KR KR1020107013008A patent/KR20100077052A/ko not_active Application Discontinuation
- 2003-01-02 DK DK03726977.6T patent/DK1461360T3/da active
-
2004
- 2004-08-02 ZA ZA200406162A patent/ZA200406162B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100077052A (ko) | 2010-07-06 |
| SI1461360T1 (sl) | 2010-12-31 |
| PT1461360E (pt) | 2010-11-23 |
| KR20040073540A (ko) | 2004-08-19 |
| ES2346750T3 (es) | 2010-10-20 |
| KR100998803B1 (ko) | 2010-12-06 |
| ZA200406162B (en) | 2005-09-27 |
| DK1461360T3 (da) | 2010-11-15 |
| ATE478095T1 (de) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04006517A (es) | Conjugados que comprenden un anticuerpo especifico para el dominio ed-b de fibronectina y sus usos para la deteccion y tratamiento de tumores. | |
| CY1120924T1 (el) | Αντισωματα εναντι-αλφα v βητα 6 και χρησεις αυτων | |
| RS80704A (en) | ANTI- av?6.ANTIBODIES | |
| CY1118693T1 (el) | Αντισωματα αντι-ακτιβινης α και χρησεις αυτων | |
| ATE443260T1 (de) | Kontrastmittel und verfahren zum imaging von naaldase oder psma | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| DK1565489T3 (da) | Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet | |
| NZ594466A (en) | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | |
| NO20072721L (no) | Polypeptides that bind BR3 and uses thereof | |
| EA200702053A1 (ru) | Антитела против cd38 для лечения множественной миеломы | |
| ATE459653T1 (de) | Monoklonale anti-cd71-antikörper und deren verwendung zur behandlung maligner tumorzellen | |
| DE60130538D1 (de) | Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung | |
| TW200626899A (en) | Frizzled proteins and detection and treatment of cancer | |
| TW200626900A (en) | Wnt proteins and detection and treatment of cancer | |
| EA200800094A1 (ru) | Антитела cd19 и их использование | |
| ATE492563T1 (de) | Vollständige humane monoklonale antikörper gegen il-13 | |
| SG170793A1 (en) | Anti-mn antibodies and methods of using same | |
| DE69942742D1 (de) | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs | |
| DE602005027399D1 (de) | Für humane matriptase spezifische bindungsproteine | |
| ATE412756T1 (de) | Verfahren zur krebsdiagnose mittels eines chimärischen toxin | |
| DE602004026872D1 (de) | Anti-hgf-r-antikörper und deren verwendung | |
| DK1572087T3 (da) | Antistoffer med cancerantigen TMEFF2 og anvendelser deraf | |
| ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
| ATE526037T1 (de) | Verfahren zum abtöten von tumorzellen mittels targeting von auf apoptotischen tumorzellen exponierten internen antigenen | |
| BRPI0407680A (pt) | métodos para diagnóstico de cáncer e diminuição de metástase por células cancerosas |